Downregulation of TRPC4 and TRPC5 Inhibits Smooth Muscle Cell Proliferation without Affecting Endothelial Cell Proliferation

AIMS: The main treatment for coronary heart disease is percutaneous coronary intervention (PCI), and drug-eluting stents are designed to inhibit vascular smooth muscle cell (VSMCs) proliferation and migration causing restenosis by releasing pharmacological agents into the vessel wall. Once drug-elut...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Wenjun, Ji, Yinan, Zhang, Haiping, Chen, Liusheng, Du, Li, Guo, Ruiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643255/
https://www.ncbi.nlm.nih.gov/pubmed/34899056
http://dx.doi.org/10.1155/2021/2949986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643255/
https://www.ncbi.nlm.nih.gov/pubmed/34899056
http://dx.doi.org/10.1155/2021/2949986

Ejemplares similares